PMID: 6105559Sep 6, 1980Paper

Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis

Lancet
A S GastanaduyL W Wannamaker

Abstract

In an outbreak of group A streptococcal pharyngitis in a semi-closed community, 42 (25%) of 169 courses of antibiotic therapy failed to eradicate the organism. 16 (19%) of 85 individuals treated with intramuscular benzathine penicillin G and 9 (19%) of 47 patients treated with an oral antibiotic (penicillin V or erythromycin) continued to harbour the same serotype of group A streptococcus. 12 (48%) of 25 persons remained treatment failures after re-treatment; even after a third course of treatment 5 of 12 (42%) still harboured the organism. Neither antibiotic resistance of the epidemic strain nor reacquisition of the organism from contacts could be implicated as causes. The data suggest that many who did not respond to treatment were streptococcal carriers and raise the possibility that it is more difficult to eradicate the organism from the carrier than from the acutely infected individual.

References

Nov 1, 1973·Antimicrobial Agents and Chemotherapy·M StillermanR R Facklam
Sep 1, 1980·The Journal of Pediatrics·E L Kaplan
Jul 10, 1958·The New England Journal of Medicine·F J CATANZAROR CHAMOVITZ
Oct 1, 1951·Proceedings of the Society for Experimental Biology and Medicine·G DAIKOS, L WEINSTEIN

❮ Previous
Next ❯

Citations

Feb 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G J van AsseltC P van Boven
Sep 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D Adam, H Scholz
Mar 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F FitoussiE Bingen
Apr 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D Milatovic, J Knauer
Oct 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J M McCarty
Jun 6, 2000·Indian Journal of Pediatrics·B OranI Erkul
Jul 29, 2004·Indian Journal of Pediatrics·Nomeeta GuptaA K Moharana
Sep 1, 1987·Indian Journal of Pediatrics·S Chaudhary
Sep 19, 2003·Current Infectious Disease Reports·Dennis L. Stevens
May 23, 2003·Current Infectious Disease Reports·Itzhak Brook
Jan 1, 1994·International Journal of Antimicrobial Agents·D L StevensS Yan
Sep 1, 1986·The Journal of Pediatrics·M A GerberE L Kaplan
Sep 12, 1991·The New England Journal of Medicine·A L Bisno
Mar 28, 2003·The New England Journal of Medicine·Daniel M Musher
May 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E L KaplanJ C Craft
Oct 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN Prevention of Invasive Group A Streptococcal Infections Workshop Participants
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Janet R Casey, Michael E Pichichero
Nov 4, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward L KaplanManfred Rohde
Aug 1, 1993·Antimicrobial Agents and Chemotherapy·D MilatovicE Materman
Oct 28, 2005·Antimicrobial Agents and Chemotherapy·Itzhak Brook, Perry A Foote
Feb 8, 2008·Acta Paediatrica·Itzhak Brook, Alan E Gober
Sep 12, 2014·Infectious Diseases in Obstetrics and Gynecology·Giv Heidari-BateniPirooz Eghtesady
Sep 1, 1996·The Journal of Pediatrics·J R CampbellC J Baker
Jun 1, 1985·The Journal of Pediatrics·R R TanzR Yogev
Sep 1, 1994·The Journal of Emergency Medicine·J A Kline, J W Runge
Mar 1, 1995·Annals of Emergency Medicine·M E Pichichero
Sep 18, 2007·Journal of Pediatric and Adolescent Gynecology·Megan T HansenKeith A Hansen
Jan 1, 1990·Scandinavian Journal of Infectious Diseases·L HolmströmT Ripa
Jul 1, 1991·The Journal of Pediatrics·R R TanzS T Shulman
Jun 12, 1998·Pediatric Annals·R R Tanz, S T Shulman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.